Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy

NCT04526886 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer
Gastric Cancer
Esophageal Cancer
Ampullary Cancer
Small Bowel Cancer
Appendix Cancer

Interventions

OTHER: Algorithm for cytopenia-related delay and dose-reduction of mFOLFOX chemotherapy

Sponsor

Dartmouth-Hitchcock Medical Center